Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2003
10/02/2003WO2003080108A1 Stable pharmaceutical composition containing factor viii
10/02/2003WO2003080107A1 Remedies for protozoan diseases
10/02/2003WO2003080106A1 Antibody fusion proteins: effective adjuvants of protein vaccination
10/02/2003WO2003080105A2 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
10/02/2003WO2003080104A2 Use of il-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases
10/02/2003WO2003080103A1 Antagonists of megalin or cubilin for use in preventing organ damage induced by therapeutic agents
10/02/2003WO2003080102A1 Method of stimulating growth and resistance to diseases of aquatic organisms
10/02/2003WO2003080101A1 Compositions and methods for inhibiting the proliferation and invasiveness of malignant cells comprising e-domain peptides of igf-i
10/02/2003WO2003080098A2 Diagnostics and therapeutics for diseases associated with homo sapiens formyl peptide receptor-like 2
10/02/2003WO2003080028A2 Method and apparatus for producing dry particles
10/02/2003WO2003080020A1 Heat-reversible composition treating hyposalia and asialia
10/02/2003WO2003079997A2 Prostaglandin f2 alpha analogs in combinaiotn with antimicrobials for treating glaucoma
10/02/2003WO2003079993A2 hGH (HUMAN GROWTH HORMONE) FORMULATIONS FOR PULMONARY ADMINISTRATION
10/02/2003WO2003079991A2 Method for administration of growth hormone via pulmonary delivery
10/02/2003WO2003079979A2 Method for treating congestive heart failure
10/02/2003WO2003079978A2 Protease activity of thrombin inhibits angiogenesis
10/02/2003WO2003079977A2 Novel compositions and methods in cancer associated with altered expression of mcm3ap
10/02/2003WO2003079969A2 Compositions and methods for treating and preventing necrosis
10/02/2003WO2003079968A2 Use of an organ-specific self-pathogen for treatment of a non-autoimmune disease of said organ
10/02/2003WO2003079966A2 Photo-active backbone cyclized somatostatin analogs for photodynamic therapy and imaging
10/02/2003WO2003079964A2 Composition for stimulating de novo bone induction
10/02/2003WO2003079885A2 Inhalable sustained therapeutic formulations
10/02/2003WO2003079818A1 Alertness bar
10/02/2003WO2003079757A2 Hiv therapeutic
10/02/2003WO2003079748A2 Potentiation of cancer therapies by znf217 inhibition
10/02/2003WO2003064441A3 Oligonucleotides comprising alternating segments and uses thereof
10/02/2003WO2003063898A3 Method of treating pain with botulinum toxin
10/02/2003WO2003062394A9 Methods and compositions for rna interference
10/02/2003WO2003061577A3 Polyalkylene glycol with moiety for conjugating biologically active compound
10/02/2003WO2003057862A3 Transdifferentiation of pancreatic acinar cells
10/02/2003WO2003056011A3 Therapeuticum and prophylacticum for malignant diseases using phenotype suppression
10/02/2003WO2003054154A3 Antisense modulation of mucin 1, transmembrane expression
10/02/2003WO2003052133A3 Oligonucleotide analogues comprising intercalator pseudonucleotides
10/02/2003WO2003051910A3 Inhibitors of hepatitis c virus protease
10/02/2003WO2003050139A3 Prion inhibiting peptides and derivatives thereof
10/02/2003WO2003049725A3 Compositions for the treatment of lupus, other rheumatic diseases and joint diseases
10/02/2003WO2003043669A8 Composition and method for treatment of wounds
10/02/2003WO2003035694A3 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof
10/02/2003WO2003033661A3 Methods of using 279, a human g protein-coupled receptor
10/02/2003WO2003033534A3 Ngzipa, ngzipd, pgzipa, and pgzipd polynucleotides and polypeptides and uses thereof
10/02/2003WO2003024991A3 Tall-1 receptor molecules and uses thereof
10/02/2003WO2003009779A3 Delivery of therapeutic capable agents
10/02/2003WO2003007793A3 Compositions, methods, and kits related to treating and diagnosing hypertension
10/02/2003WO2003006604A3 Cyclic peptides as potent and selective melanocortin-4 receptor agonists
10/02/2003WO2003000901A8 Nucleic acids encoding protein kinases
10/02/2003WO2002096935A3 Long lasting fusion peptide inhibitors for hiv infection
10/02/2003WO2002092759A3 Molecules for disease detection and treatment
10/02/2003WO2002085405A3 COMBINATION THERAPY USING ANTI-ANGIOGENIC AGENTS AND TNF$g(a)
10/02/2003WO2002081691A9 Abcg5 and abcg8: compositions and methods of use
10/02/2003WO2002080852A3 Genes expressed in intestinal epithelium and peyer's patch m cells
10/02/2003WO2002079473A3 Molecules for diagnostics and therapeutics
10/02/2003WO2002074323A3 Using neural thread proteins to treat tumors and other hyperproliferative disorders
10/02/2003WO2002064158A3 Use of a conjugate of il-6 and the receptor thereof for inducing cellular expression of scf and flt-3l
10/02/2003WO2002061037A3 Administration of nucleic acid sequence to female animal
10/02/2003WO2002057419A3 Protein-protein interactions
10/02/2003WO2002054872A8 Liquid antimicrobial compositions
10/02/2003WO2002041763A3 Compositions and methods for the therapy and diagnosis of colon cancer
10/02/2003WO2002036614A3 Peptides for use in the treatment of alzheimer's disease
10/02/2003WO2002030940A3 Low molecular serine protease inhibitors comprising polyhydroxy-alkyl and polyhydroxy-cycloalkyl radicals
10/02/2003WO2002026781A3 Ige receptor antagonists
10/02/2003WO2002026246A3 Pharmaceutical compositions comprising polynucleotides encoding a raf protein
10/02/2003WO2002022573A3 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
10/02/2003WO2002020570A3 Mitochondrial membrane permeabilization bv hiv-1 vpr and methods of screening
10/02/2003WO2002008383A3 Sp110, a polypeptide component of the nuclear body
10/02/2003WO2002006315A3 Novel nucleic acid and amino acid sequences
10/02/2003WO2002002623A3 Compositions and methods for the therapy and diagnosis of lung cancer
10/02/2003WO2002000243A3 Stabilized interleukin 2
10/02/2003WO2001098491A3 Osteolevin gene polymorphisms
10/02/2003WO2001090155A3 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
10/02/2003WO2001005355A3 Formulations for il-11
10/02/2003US20030188327 Compositions and methods for the treatment and diagnosis of cardiovascular disease
10/02/2003US20030187247 Immunoglobulin for use in prevention and treatment of viral diseases; immunotheray; immunoassay
10/02/2003US20030187246 Nucleic acids and proteins of C. elegans insulin-like genes and uses thereof
10/02/2003US20030187245 Comprises expression vectors coding proteins for regulation and expression of transgenes and treatment of allergies, inflammation, arthritis and nervous system disorders; gene therapy; antiproliferative agents
10/02/2003US20030187244 Comprises membrane protein for use in the treatment of nervous system, cell proliferative, respiratory, hematopoietic, eating and obesity disorders
10/02/2003US20030187242 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187241 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187240 Nuclease resistant
10/02/2003US20030187239 Comprises nucleotide sequences coding membrane proteins for use as antiproliferative/antitumor/antiinflammatory agents; drug screening
10/02/2003US20030187238 Comprises nucleotide sequences coding membrane proteins for use as antiproliferative/antitumor/antiinflammatory agents; drug screening
10/02/2003US20030187231 Humanized anti-TNF antibodies and peptides
10/02/2003US20030187230 Chimeric humanized monoclonal antibody for treating tumors and inflammation
10/02/2003US20030187229 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187228 Chimeric humanized monoclonal antibody for treating tumors and inflammation
10/02/2003US20030187225 Antibody fusion proteins: effective adjuvants of protein vaccination
10/02/2003US20030187224 Chimeric OPG polypeptides
10/02/2003US20030187223 Secreted frizzled related protein,sFRP, fragments and methods of use thereof
10/02/2003US20030187221 Peptides for the preparation of vaccines against bordetella pertussis and bordetella parapertussis
10/02/2003US20030187200 Comprises nucleotide sequences coding kunitz-type protease inhibitor for treating reproductive, hemostatic and inflammatory disorders
10/02/2003US20030187197 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187196 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187195 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187193 Comprises nucleotide sequences coding membrane protein for use as antitumor/anticarcinogenic/antiinflammatory/antiproliferative agents
10/02/2003US20030187192 Comprises nucleotide sequences coding membrane protein for use as antitumor/anticarcinogenic/antiinflammatory/antiproliferative agents
10/02/2003US20030187191 Comprises nucleotide sequences coding membrane protein for use as antitumor/anticarcinogenic/antiinflammatory/antiproliferative agents
10/02/2003US20030187190 Comprises nucleotide sequences coding membrane protein for use as antitumor/anticarcinogenic/antiinflammatory/antiproliferative agents
10/02/2003US20030187189 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187187 Polypeptide with appetite regulating activity
10/02/2003US20030187186 Glycopeptide and preparation thereof
10/02/2003US20030187184 Viral peptide for use in diagnosis and treatment of liver disorders; genetic vaccines
1 ... 1758 1759 1760 1761 1762 1763 1764 1765 1766 1767 1768 1769 1770 1771 1772 1773 1774 1775 1776 1777 1778 ... 3163